Management of immune checkpoint therapy for patients with cancer in the face of COVID-19

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

(2020) Wenhua Liang et al.   LANCET ONCOLOGY

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

(2020) Zhe Xu et al.   Lancet Respiratory Medicine

Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients

(2020) Hong-Yi Zheng et al.   Cellular & Molecular Immunology

The many faces of the anti-COVID immune response

(2020) Santosha A. Vardhana et al.   JOURNAL OF EXPERIMENTAL MEDICINE

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study

(2020) Lennard Y W Lee et al.   LANCET

Immune checkpoint inhibitors in SARS-CoV-2 infected cancer patients: the spark that ignites the fire?

(2020) Vincenzo Di Noia et al.   LUNG CANCER

Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak

(2020) Mengyuan Dai et al.   Cancer Discovery

Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers

(2020) Jia Luo et al.   Cancer Discovery

Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System

(2020) Vikas Mehta et al.   Cancer Discovery

Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients

(2020) Yonggang Zhou et al.   National Science Review

SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China

(2020) Jing Yu et al.   JAMA Oncology

A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab

(2020) Lucia Bonomi et al.   Journal of Thoracic Oncology

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

(2020) Marina Chiara Garassino et al.   LANCET ONCOLOGY

Determinants of COVID-19 disease severity in patients with cancer

(2020) Elizabeth V. Robilotti et al.   NATURE MEDICINE

Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia

(2020) Sara De Biasi et al.   Nature Communications

Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer

(2019) Jacques Cadranel et al.   European Respiratory Review

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis

(2019) Hanping Wang et al.   Thoracic Cancer

Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology

(2017) Rudragouda Channappanavar et al.   Seminars in Immunopathology

The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma

(2016) Maria Del Castillo et al.   CLINICAL INFECTIOUS DISEASES